Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / Lupin (company)

United States — Food and Drug Administration & Lupin (company)

1 shared events · Importance 3 · Last updated Jun 27, 2026

Importance
3
Shared Events
1
Actions
1
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
89
Regulatory
Lupin gets US FDA approval
United States — Food and Drug Administration: The United States — Food and Drug Administration granted tentative approval for Lupin (company)'s Enzalutamide Tablets, acting as the regulatory body overseeing drug approvals in the U.S.
Lupin (company): Lupin (company) received tentative approval from the U.S. FDA for its Enzalutamide Tablets, which is a positive development for the company as it expands its product offerings and market reach.
Jun 26, 2026 · 16 articles
Actions (1)
100 United States — Food and Drug Administration granted tentative approval Lupin (company)Lupin gets US FDA approval
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and Lupin (company) interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.